Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,660,682
+$12,617 QoQ
Shares Held
4,586
-2.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#1,384
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argent Advisors, Inc. holds $22,940,677 across 9 Drug Manufacturers - General names. AMGN ranks #6 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,391 | $5,266,697 | |
| 2 | JNJ |
Johnson & Johnson
|
20,074 | $5,098,193 | |
| 3 | MRK |
Merck & Co., Inc.
|
24,547 | $3,154,289 | |
| 4 | GSK |
GSK plc
|
51,943 | $2,722,852 | |
| 5 | PFE |
Pfizer Inc
|
109,643 | $2,640,203 | |
| 6 | AMGN |
Amgen Inc
This page
|
4,586 | $1,660,682 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
11,701 | $1,478,304 | |
| 8 | ABBV |
AbbVie Inc.
|
2,592 | $652,250 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,660,682 | 4,586 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,648,065 | 4,684 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $1,565,196 | 4,782 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,326,340 | 4,700 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $1,321,780 | 4,734 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,441,853 | 4,628 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $1,087,390 | 4,172 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,329,116 | 4,125 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,279,170 | 4,094 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $1,089,514 | 3,832 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,065,097 | 3,698 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $991,724 | 3,690 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $758,420 | 3,416 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $808,895 | 3,346 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $837,821 | 3,190 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $686,793 | 3,047 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $711,409 | 2,924 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $685,317 | 2,834 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,183,567 | 5,261 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $1,005,621 | 4,729 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $939,168 | 3,853 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $839,733 | 3,375 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $1,012,797 | 4,405 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $1,024,264 | 4,030 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $946,506 | 4,013 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $257,467 | 1,270 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||